CERTIFIED IN AMBULATORY ACCESS LEADERSHIP Trademark

Trademark Overview


On Tuesday, August 6, 2024, a trademark application was filed for CERTIFIED IN AMBULATORY ACCESS LEADERSHIP with the United States Patent and Trademark Office. The USPTO has given the CERTIFIED IN AMBULATORY ACCESS LEADERSHIP trademark a serial number of 98684487. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, February 24, 2025. This trademark is owned by Patient Access Symposium, LLC. The CERTIFIED IN AMBULATORY ACCESS LEADERSHIP trademark is filed in the category with the following description:

ambulatory access leadership
certified in ambulatory access leadership

General Information


Serial Number98684487
Word MarkCERTIFIED IN AMBULATORY ACCESS LEADERSHIP
Filing DateTuesday, August 6, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, February 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesambulatory access leadership

Classification Information


International ClassB -
US Class CodesB
Class Status Code6 - Active
Class Status DateTuesday, August 6, 2024
Primary CodeB
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePatient Access Symposium, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30306

Trademark Events


Event DateEvent Description
Tuesday, August 6, 2024NEW APPLICATION ENTERED
Sunday, February 23, 2025ASSIGNED TO EXAMINER
Saturday, February 22, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 24, 2025NON-FINAL ACTION E-MAILED
Monday, February 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 24, 2025NON-FINAL ACTION WRITTEN
Tuesday, March 11, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, March 11, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED